Bionaut Labs

company

About

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$43.20M
Industries
Biopharma,Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2016
Number Of Employee
1 - 10
Operating Status
Active

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index for efficacy and maintain safety.

Bionaut Labs is focused on helping patients suffering from debilitating brain diseases who have few available treatment options. The anatomical targeting capabilities of the Bionaut platform make new therapeutics technologies such as gene therapy, CRISPR-Cas9, and oncolytic viruses viable in challenging clinical settings.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$43.20M
Bionaut Labs has raised a total of $43.20M in funding over 2 rounds. Their latest funding was raised on Nov 28, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 28, 2022 Series B $43.20M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Bionaut Labs is funded by 2 investors. OurCrowd and Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
OurCrowd Series B
Gaingels Series B